Basket | Login | Register

 
 
 
 

Malta

Reimbursement of anti-dementia drugs

The availability of medicines in general

According to information from the website of the Health Division (Ministry of Health) [1] , the government supplies medicines free of charge to all in-patients in government hospitals. Medicines are supplied for free from government pharmacies and district clinics to entitled persons. There are two schedules under the Social Security Act Cap. 318 to grant free medicines:

  • Schedule II (referred to as the Pink Card), entitles households with low total income (means tested) to medicines listed in the Government Formulary, subject to completion of certain requirements (e.g. hospital consultant's signature in the case of certain medicines). A Pink Card can also be issued for people with tuberculosis, leprosy or poliomyelitis and their after effects. People with diabetes can also benefit from this schedule.
  • Schedule V (referred to as the Yellow Card), entitles people with diseases listed under the fifth schedule of the Social Security Act to free medicines for that condition irrespective of financial position. These include many chronic diseases such as malignanty, cancers, chronic cardiovascular and respiratory disease, endocrine diseases, schizophrenia and others. Certain conditions such as stroke, dementia and depression are not included. The list was last updated in 1999.

Other persons entitled to free drugs (who are issued a Grey Card that has the same function as the pink card) are members of religious orders, inmates of charitable institutions, certain grades of employees in the Health Division, certain grades of employees in the police and armed forces, prisoners, and persons injured on government duty.

The availability of Alzheimer treatments

All four anti-dementia drugs are available to patients in Malta. Alzheimer’s disease is not on the list of covered diseases (schedule V) and anti-dementia drugs thus need to be funded through out-of-pocket payments. Prescriptions can be effected both by specialists and family doctors.

 

Donepezil

Rivastigmine

Galantamine

Memantine

Reimbursement

No

No

No

No

Initial treatment decision

N/A

N/A

N/A

N/A

Continuing treatment decision

N/A

N/A

N/A

N/A

Required examinations

None

None

None

None

MMSE limits

N/A

N/A

N/A

N/A

People living alone

N/A

N/A

N/A

N/A

People in nursing homes

N/A

N/A

N/A

N/A

[1] Health Division: Free medicinals. Accessed 1st September 2006 from www.sahha.gov.mt

 

 
 

Last Updated: mercredi 15 juillet 2009

 

 
 

Options

  • Send this page to a friend